CYP2D6 genotype and adverse events to risperidone in children and adolescents.

Oshikoya, Kazeem A; Neely, Katelyn M; Carroll, Robert J; Aka, Ida T; Maxwell-Horn, Angela C; Roden, Dan M; Van Driest, Sara L

Oshikoya, Kazeem A; Neely, Katelyn M; Carroll, Robert J; Aka, Ida T; Maxwell-Horn, Angela C; Roden, Dan M; Van Driest, Sara L.

Afiliação

Oshikoya KA; Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN, USA.
Neely KM; Department of Pediatrics, Vanderbilt University School of Medicine, Nashville, TN, USA.
Carroll RJ; Department of Biomedical Informatics, Vanderbilt University School of Medicine, Nashville, TN, USA.
Aka IT; Department of Pediatrics, Vanderbilt University School of Medicine, Nashville, TN, USA.
Maxwell-Horn AC; Department of Pediatrics, Vanderbilt University School of Medicine, Nashville, TN, USA.
Roden DM; Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN, USA.
Van Driest SL; Department of Pediatrics, Vanderbilt University School of Medicine, Nashville, TN, USA. sara.van.driest@vumc.org.

Pediatr Res ; 85(5): 602-606, 2019 04.

Article em En | MEDLINE | ID: mdl-30661084

Assuntos

Citocromo P-450 CYP2D6/genética; Farmacogenética; Polimorfismo Genético; Risperidona/efeitos adversos; Adolescente; Alelos; Criança; Registros Eletrônicos de Saúde; Feminino; Genótipo; Humanos; Masculino; Fenótipo; Estudos Retrospectivos; Risco; Resultado do Tratamento

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Farmacogenética / Polimorfismo Genético / Risperidona / Citocromo P-450 CYP2D6 Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Child / Female / Humans / Male Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google